A Novel Pharmacological Therapy for Obstructive Sleep Apnea

NCT03919955 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

117

Enrollment

OTHER

Sponsor class

Conditions

Sleep Apnea

Interventions

DRUG: Atomoxetine
DRUG: Oxybutynin
DRUG: Placebo

Sponsor

Brigham and Women's Hospital

Collaborators

[object Object]